16 results
424B4
APTO
Aptose Biosciences Inc
26 Jan 24
Prospectus supplement with pricing info
5:30pm
60, joined Aptose as Senior Vice President and Chief Financial Officer (“CFO”) in June 2022. With a healthcare tenure of more than two decades, Mr
8-K
EX-99.1
u67ksplbk16o9z459
30 Nov 23
Aptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive Role
5:28pm
8-K
EX-99.1
3zi0a3n
16 Sep 22
Departure of Directors or Certain Officers
5:15pm
8-K
EX-99.1
hqyyzopp3y 04ux447w
13 Sep 22
Regulation FD Disclosure
8:44am
8-K
EX-99.1
ti7xxn4tljjf3ar5
2 Aug 22
Aptose Reports Results for the Second Quarter 2022
4:10pm
8-K
EX-99.1
w9p2lyv9 brihbwzq
27 Jun 22
Aptose Appoints Fletcher Payne as Senior Vice President, Chief Financial Officer
2:29pm
6-K
EX-99.1
113w2w2
2 Dec 11
Lorus Therapeutics Provides Corporate Update
12:00am
6-K
EX-99.4
5p9ug
8 Jun 07
Current report (foreign)
12:00am
6-K
EX-99.2
9wiv1
12 Dec 05
6-K Filing for Lorus Therapeutics
12:00am
- Prev
- 1
- Next